The genetics of dementia with Lewy bodies: What are we missing?

Archives of Neurology

Volumn 69, Issue 9, 2012, Pages 1113-1118

  Meeus, Bram ^a   Theuns, Jessie ^a   Van Broeckhoven, Christine ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E;

ALZHEIMER DISEASE; AUTONOMIC DYSFUNCTION; COMORBIDITY; DEGENERATIVE DISEASE; DEMENTIA; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; HERITABILITY; HUMAN; LEWY BODY; MISSENSE MUTATION; MOLECULAR GENETICS; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW;

ALPHA-SYNUCLEIN; AMYLOID BETA-PROTEIN PRECURSOR; BRAIN; HUMANS; LEWY BODIES; LEWY BODY DISEASE; PRESENILINS;

EID: 84866116962     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2011.3678     Document Type: Review

References (35)

1. McKeith IG, Dickson DW, Lowe J, et al; Consortium on DLB. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium [published correction appears in Neurology. 2005;65(12):1992]. Neurology. 2005;65(12):1863-1872. (Pubitemid 43970103)
2. Wang CS, Burke JR, Steffens DC, Hulette CM, Breitner JC, Plassman BL. Twin pairs discordant for neuropathologically confirmed Lewy body dementia. J Neurol Neurosurg Psychiatry. 2009;80(5):562-565.
3. Nervi A, Reitz C, Tang MX, et al. Familial aggregation of dementiawith Lewy bodies. Arch Neurol. 2011;68(1):90-93.
4. Golbe LI, Di Iorio G, Bonavita V, Miller DC, Duvoisin RC. A large kindred with autosomal dominant Parkinson's disease. Ann Neurol. 1990;27(3):276-282. (Pubitemid 20122379)
5. Waters CH, Miller CA. Autosomal dominant Lewy body parkinsonism in a four-generation family. Ann Neurol. 1994;35(1):59-64. (Pubitemid 24027607)
6. Denson MA, Wszolek ZK, Pfeiffer RF, Wszolek EK, Paschall TM, McComb RD. Familial parkinsonism, dementia, and Lewy body disease: study of family G. Ann Neurol. 1997;42(4):638-643. (Pubitemid 27439027)
7. Ishikawa A, Piao YS, Miyashita A, et al. A mutant PSEN1 causes dementia with Lewy bodies and variant Alzheimer's disease. Ann Neurol. 2005;57(3):429-434. (Pubitemid 40343966)
8. Ohara K, Takauchi S, Kokai M, Morimura Y, Nakajima T, Morita Y. Familial dementia with Lewy bodies (DLB). Clin Neuropathol. 1999;18(5):232-239. (Pubitemid 29422203)
9. Spira PJ, Sharpe DM, Halliday G, Cavanagh J, Nicholson GA. Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr α-synuclein mutation. Ann Neurol. 2001;49(3):313-319. (Pubitemid 32202784)
10. Brett FM, Henson C, Staunton H. Familial diffuse Lewy body disease, eye movement abnormalities, and distribution of pathology. Arch Neurol. 2002;59(3):464-467. (Pubitemid 34208158)
11. Galvin JE, Uryu K, Lee VM, Trojanowski JQ. Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains α-, β-, and γ-synuclein. Proc Natl Acad Sci U S A. 1999;96(23):13450-13455.
12. Tsuang DW, Dalan AM, Eugenio CJ, et al. Familial dementia with lewy bodies: a clinical and neuropathological study of 2 families. Arch Neurol. 2002;59(10):1622-1630.
13. Tsuang DW, DiGiacomo L, Bird TD. Familial occurrence of dementia with Lewy bodies. Am J Geriatr Psychiatry. 2004;12(2):179-188. (Pubitemid 38250301)
14. Bonner LT, Tsuang DW, Cherrier MM, et al. Familial dementia with Lewy bodies with an atypical clinical presentation. J Geriatr Psychiatry Neurol. 2003;16(1):59-64. (Pubitemid 37408292)
15. Zarranz JJ, Alegre J, Gómez-Esteban JC, et al. The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia. Ann Neurol. 2004;55(2):164-173. (Pubitemid 38166992)
16. Bogaerts V, Engelborghs S, Kumar-Singh S, et al. A novel locus for dementia with Lewy bodies: a clinically and genetically heterogeneous disorder. Brain. 2007;130(Pt 9):2277-2291. (Pubitemid 47327632)
17. Meeus B, Nuytemans K, Crosiers D, et al. Comprehensive genetic and mutation analysis of familial dementia with Lewy bodies linked to 2q35-q36. J Alzheimers Dis. 2010;20(1):197-205.
18. Nuytemans K, Theuns J, Cruts M, Van Broeckhoven C. Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update. Hum Mutat. 2010;31(7):763-780.
19. Fan Y, Limprasert P, Murray IV, et al. β-synuclein modulates α-synuclein neurotoxicity by reducing α-synuclein protein expression. Hum Mol Genet. 2006;15(20):3002-3011.
20. Ninkina N, Peters O, Millership S, Salem H, van der Putten H, Buchman VL. γ-synucleinopathy: neurodegeneration associated with overexpression of the mouse protein. Hum Mol Genet. 2009;18(10):1779-1794.
21. Nishioka K, Wider C, Vilariño-Güell C, et al. Association of α-, β-, and γ-Synuclein with diffuse lewy body disease. Arch Neurol. 2010;67(8):970-975.
22. Ohtake H, Limprasert P, Fan Y, et al. β-synuclein gene alterations in dementia with Lewy bodies. Neurology. 2004;63(5):805-811.
23. Wei J, Fujita M, Nakai M, et al. Enhanced lysosomal pathology caused by β-synuclein mutants linked to dementia with Lewy bodies. J Biol Chem. 2007;282(39):28904-28914.
24. Guyant-Marechal I, Berger E, Laquerrière A, et al. Intrafamilial diversity of phenotype associated with app duplication. Neurology. 2008;71(23):1925-1926.
25. Sleegers K, Brouwers N, Gijselinck I, et al. APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy. Brain. 2006;129(Pt 11):2977-2983. (Pubitemid 44684518)
26. Kaneko H, Kakita A, Kasuga K, et al. Enhanced accumulation of phosphorylated α-synuclein and elevated β-amyloid 42/40 ratio caused by expression of the presenilin-1 deltaT440 mutant associated with familial Lewy body disease and variant Alzheimer's disease. J Neurosci. 2007;27(48):13092- 13097.
27. Anderson JP, Walker DE, Goldstein JM, et al. Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease. J Biol Chem. 2006;281(40):29739-29752.
28. Meeus B, Verstraeten A, Crosiers D, et al. DLB and PDD: a role for mutations in dementia and Parkinson disease genes [published online November 26, 2011]. Neurobiol Aging. 2012;33(3):e5-620.e18. doi:10.1016/j.neurobiolaging. 2011.10.014.
29. Sidransky E, Nalls MA, Aasly JO, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med. 2009;361(17):1651-1661.
30. Clark LN, Kartsaklis LA, Wolf Gilbert R, et al. Association of glucocerebrosidase mutations with dementia with lewy bodies. Arch Neurol. 2009;66(5):578-583.
31. Cullen V, Sardi SP, Ng J, et al. Acid β-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter α-synuclein processing. Ann Neurol. 2011;69(6):940-953.
32. Kobayashi S, Tateno M, Park TW, et al. Apolipoprotein E4 frequencies in a Japanese population with Alzheimer's disease and dementia with Lewy bodies. PLoS One. 2011;6(4):e18569 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084234/? tool=pubmed. Accessed March 29, 2012.
33. antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature. 1994;372(6501):92-94.
34. Theuns J, Brouwers N, Engelborghs S, et al. Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease. Am J Hum Genet. 2006;78(6):936-946. (Pubitemid 43787686)
35. Voutsinas GE, Stavrou EF, Karousos G, et al. Allelic imbalance of expression and epigenetic regulation within the α-synuclein wild-type and p.Ala53Thr alleles in Parkinson disease. Hum Mutat. 2010;31(6):685-691.